Chemistry and bioactivity of lindenane sesquiterpenoids and their oligomers
Author:
Affiliation:
1. Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
Abstract
Funder
National Natural Science Foundation of China
China Pharmaceutical University
Ministry of Education of the People's Republic of China
Publisher
Royal Society of Chemistry (RSC)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2024/NP/D3NP00022B
Reference232 articles.
1. P. K.Mukherjee , Quality Control and Evaluation of Herbal Drugs , 2019 , pp. 237–328
2. Tricyclic Sesquiterpenes from Marine Origin
3. Artemisinin, a miracle of traditional Chinese medicine
4. T.Xie , in Elemene Antitumor Drugs , Elsevier , 2023 , vol. 1–8 , pp. 1–298
5. The genus Lindera: a source of structurally diverse molecules having pharmacological significance
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Holotrichones A and B, potent anti-leukemic lindenane-type sesquiterpene trimers with unprecedented complex carbon skeletons from a rare Chloranthus species;Chinese Chemical Letters;2024-12
2. The total biosynthesis route of rosmarinic acid in Sarcandra glabra based on transcriptome sequencing;Plant Physiology and Biochemistry;2024-10
3. Sesquiterpene dimers with a rare skeleton from Chloranthus holostegius exhibiting multidrug resistance reversal activity in vitro and in vivo;Fitoterapia;2024-09
4. Chloranthalactone B covalently binds to the NACHT domain of NLRP3 to attenuate NLRP3-driven inflammation;Biochemical Pharmacology;2024-08
5. Lindenane sesquiterpenoid dimers with NLRP3 inflammasome inhibitory activities from Chloranthus holostegius var. shimianensis;Biomedicine & Pharmacotherapy;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3